ROR1 CAR-T cells exhibited significantly higher cytotoxicity against the NCI-H1299 cell line, while demonstrating limited activity against primary tumor cells from patients who had undergone multiple rounds of treatment (Fig. 1G). The gene discussed is ROR1; the disease is neoplasm.